Triamterene and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Triamterene and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | triamterene and hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1996-06-07 |
| END MARKETING DATE: | 0000-00-00 |
Triamterene and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Triamterene and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 37.5(mg/1; mg/1) |
| START MARKETING DATE: | 1996-06-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-2537_9641f4e0-df7d-4f95-9b2c-1fad2c9ee089 |
| PRODUCT NDC: | 0378-2537 |
| APPLICATION NUMBER: | ANDA074701 |
Other HYDROCHLOROTHIAZIDE; TRIAMTERENE Pharmaceutical Manufacturers / Labelers:
